The potential roles of IL-6 on cardiovascular risk had been postulated in patients with T2DM and unstable CAD [33,34], but the changes of IL-6 had ever been reported poorly correlated to insulin sensitivity in patients with AbnGT [35]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.